Buy Cabaser (Cabergoline) Online

Cabaser is an oral medication that is used in the management of the signs and symptoms of Parkinson’s disease. It contains the active ingredient cabergoline, which is a dopaminergic ergoline derivative endowed with potent and long-lasting dopamine D2 receptor agonist properties.

Cabergoline belongs to a class of drugs called dopamine agonists which bind to dopamine receptors in the brain. It can cause dizziness, especially during the first few days of use, and bottles of the medication have been identified to be counterfeited.

Cabaser comes in the form of tablet to take it by mouth with or without food as directed by your doctor, usually taken twice a week. Swallow Cabaser tablets whole with a full glass of water. Chewing or crushing the tablets may affect the way the medication is absorbed by your body and may increase the risk of side effects.

The dosage and frequency of Cabaser will depend on the individual’s condition and their response to treatment. However, your doctor will tell you how many tablets to take. The usual starting dose is half to one 1 mg tablet (0.5 mg to 1 mg) a day. Your doctor will gradually increase your dose over several weeks. The recommended maintenance dose is 2 mg to 3 mg a day. The exact dosage and frequency should be determined by the prescribing doctor. Take cabergoline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Do not stop taking cabergoline without talking to your doctor. Your doctor will decrease your dose gradually.

If you miss a dose of Cabaser, take it as soon as you remember. However, if it is close to the time of your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.

Common Side Effects of Cabaser (Cabergoline):

Breast pain
Burning, numbness, or tingling in the arms, hands, legs, or feet
Constipation
Dizziness
Heartburn
Nausea
Painful menstrual periods
Tiredness
Vomiting

Serious side effects of cabaser (cabergoline):

Abnormal vision
Chest pain
Cough
Decrease in urination
Difficulty breathing when lying down
Lumps or pain in the stomach area
Pain in the back, side, or groin
Shortness of breath
Swelling of the hands, feet, ankles, or lower legs

Cabaser (Cabergoline) is available in the following forms and strength:

Cabaser: Tablet

1 mg
2 mg

Cabaser may cause dizziness, particularly during the first few days of use, so avoid driving or operating heavy machinery until the individual knows how the tablet affects them.
Cabaser may cause drowsiness or sleepiness, so avoid alcohol consumption and activities that require mental alertness or physical coordination until the individual knows how the tablet affects them.
Cabaser may cause low blood pressure, which can lead to dizziness or fainting, particularly when the individual stands up. Rise slowly from a sitting or lying position, to avoid sudden changes in posture.
Cabaser may interact with other medications, including some antidepressants, blood pressure medications, and medications that affect the liver. Inform the prescribing doctor about all medications, supplements, and herbal remedies that the individual is taking to avoid potentially harmful interactions.
Cabaser should not be taken during pregnancy or if the individual is breastfeeding. Inform the prescribing doctor if the individual is pregnant or planning to become pregnant.
Cabaser may cause or exacerbate mental health problems, including depression, anxiety, and hallucinations. Report any changes in mood or behavior to the prescribing doctor.
Cabaser may affect the immune system, leading to an increased risk of infections. Report any signs of infection to the prescribing doctor.
Cabaser may cause or exacerbate pulmonary and retroperitoneal fibrosis, a condition where fibrous tissue builds up in the lungs or abdomen. This can lead to breathing difficulties, chest pain, and abdominal pain. Report any symptoms to the prescribing doctor.
Cabaser may cause or exacerbate heart valve disorders, including heart valve fibrosis and regurgitation. Report any symptoms of heart problems, such as shortness of breath, chest pain, or swelling in the legs, to the prescribing doctor.
Cabaser may increase the risk of compulsive behaviors, such as gambling, shopping, or eating. Report any unusual changes in behavior to the prescribing doctor.
Cabaser may cause or exacerbate Raynaud’s syndrome, a condition where the blood vessels in the fingers and toes narrow in response to cold or stress, leading to pain, numbness, and tingling. Report any symptoms to the prescribing doctor.
Cabaser may cause or exacerbate gastrointestinal problems, such as nausea, vomiting, and constipation. Report any symptoms to the prescribing doctor.
Cabaser may cause or exacerbate liver problems, particularly if the individual has a history of liver disease. Report any symptoms of liver problems, such as jaundice or abdominal pain, to the prescribing doctor.
Cabaser may cause or exacerbate kidney problems, particularly if the individual has a history of kidney disease. Report any symptoms of kidney problems, such as changes in urination or swelling in the legs, to the prescribing doctor.

Can Cabaser cause addiction or dependence?

Cabaser has not been shown to cause addiction or dependence with proper use. However, it should only be taken under the direction of a healthcare provider, and the individual’s condition and response to treatment should be monitored regularly.

How should I store Cabaser?

Cabaser should be stored in a cool and dry place, away from direct sunlight and moisture. It should be kept out of the reach of children and pets.

How long will I need to take Cabaser?

The length of time an individual will need to take Cabaser will depend on their condition and response to treatment. Some individuals may only need to take it for a few weeks or months, while others may need to take it for longer periods of time.

Can Cabaser be used in children?

Cabaser is not recommended for use in children, as its safety and effectiveness have not been established in this population. It should only be used in individuals who are over 18 years old and have been diagnosed with hyperprolactinemia by a healthcare provider.